HEADER SIGNALING PROTEIN, TRANSFERASE 14-OCT-21 7SIU TITLE CRYSTAL STRUCTURE OF HPK1 (MAP4K1) COMPLEX WITH INHIBITOR A-745 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HEMATOPOIETIC PROGENITOR KINASE,MAPK/ERK KINASE KINASE COMPND 5 KINASE 1,MEK KINASE KINASE 1,MEKKK 1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP4K1, HPK1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK (293-6E) KEYWDS PROTEIN KINASE, SIGNALING PROTEIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.L.LONGENECKER,A.KOREPANOVA,W.QIU REVDAT 3 18-OCT-23 7SIU 1 REMARK REVDAT 2 30-MAR-22 7SIU 1 JRNL REVDAT 1 02-MAR-22 7SIU 0 JRNL AUTH S.MALCHOW,A.KOREPANOVA,S.C.PANCHAL,R.A.MCCLURE, JRNL AUTH 2 K.L.LONGENECKER,W.QIU,H.ZHAO,M.CHENG,J.GUO,K.L.KLINGE, JRNL AUTH 3 P.TRUSK,S.D.PRATT,T.LI,M.D.KURNICK,L.DUAN,A.R.SHOEMAKER, JRNL AUTH 4 S.M.GOPALAKRISHNAN,S.E.WARDER,J.B.SHOTWELL,A.LAI,C.SUN, JRNL AUTH 5 A.T.OSUMA,W.N.PAPPANO JRNL TITL THE HPK1 INHIBITOR A-745 VERIFIES THE POTENTIAL OF JRNL TITL 2 MODULATING T CELL KINASE SIGNALING FOR IMMUNOTHERAPY. JRNL REF ACS CHEM.BIOL. V. 17 556 2022 JRNL REFN ESSN 1554-8937 JRNL PMID 35188729 JRNL DOI 10.1021/ACSCHEMBIO.1C00819 REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 (19-MAR-2020) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 80.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 75564 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 3744 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.77 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1512 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2354 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1431 REMARK 3 BIN R VALUE (WORKING SET) : 0.2347 REMARK 3 BIN FREE R VALUE : 0.2476 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.36 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 81 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4541 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 67 REMARK 3 SOLVENT ATOMS : 704 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.73660 REMARK 3 B22 (A**2) : -1.73660 REMARK 3 B33 (A**2) : 3.47320 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.200 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.115 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.104 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.104 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.097 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4712 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6382 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1639 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 825 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4712 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 596 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4630 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.88 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.30 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.04 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7SIU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1000260366. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-OCT-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 75564 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.786 REMARK 200 RESOLUTION RANGE LOW (A) : 80.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 11.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3GGF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG1000, 100 MM LI2SO4, 100 MM REMARK 280 SODIUM CITRATE, PH 5.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 161.79500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 34.68500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 34.68500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 80.89750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 34.68500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 34.68500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 242.69250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 34.68500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 34.68500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 80.89750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 34.68500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 34.68500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 242.69250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 161.79500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -59.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -15 REMARK 465 ASP A -14 REMARK 465 TYR A -13 REMARK 465 LYS A -12 REMARK 465 ASP A -11 REMARK 465 ASP A -10 REMARK 465 ASP A -9 REMARK 465 ASP A -8 REMARK 465 LYS A -7 REMARK 465 GLU A -6 REMARK 465 GLY A 1 REMARK 465 ASP A 2 REMARK 465 VAL A 3 REMARK 465 VAL A 4 REMARK 465 GLY A 295 REMARK 465 MET B -15 REMARK 465 ASP B -14 REMARK 465 TYR B -13 REMARK 465 LYS B -12 REMARK 465 ASP B -11 REMARK 465 ASP B -10 REMARK 465 ASP B -9 REMARK 465 ASP B -8 REMARK 465 LYS B -7 REMARK 465 GLU B -6 REMARK 465 GLY B 1 REMARK 465 ASP B 2 REMARK 465 VAL B 3 REMARK 465 VAL B 4 REMARK 465 ASP B 5 REMARK 465 PRO B 6 REMARK 465 ASP B 7 REMARK 465 ILE B 8 REMARK 465 PHE B 9 REMARK 465 ASN B 10 REMARK 465 ARG B 11 REMARK 465 ASP B 12 REMARK 465 PRO B 13 REMARK 465 ARG B 14 REMARK 465 ASP B 15 REMARK 465 GLY B 295 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A -1 CG CD OE1 NE2 REMARK 470 GLN B -1 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 20 -143.22 -103.27 REMARK 500 ASP A 137 42.24 -142.49 REMARK 500 LYS A 240 -72.38 -101.18 REMARK 500 LEU A 255 48.61 -92.11 REMARK 500 ASP B 137 32.18 -143.32 REMARK 500 VAL B 186 59.77 27.46 REMARK 500 ALA B 187 -71.78 -97.22 REMARK 500 LEU B 211 -3.02 79.41 REMARK 500 LEU B 255 42.86 -92.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1352 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A1353 DISTANCE = 6.76 ANGSTROMS REMARK 525 HOH B 745 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH B 746 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH B 747 DISTANCE = 6.43 ANGSTROMS REMARK 525 HOH B 748 DISTANCE = 6.64 ANGSTROMS REMARK 525 HOH B 749 DISTANCE = 6.83 ANGSTROMS REMARK 525 HOH B 750 DISTANCE = 7.13 ANGSTROMS REMARK 525 HOH B 751 DISTANCE = 7.25 ANGSTROMS DBREF 7SIU A 2 295 UNP Q92918 M4K1_HUMAN 2 295 DBREF 7SIU B 2 295 UNP Q92918 M4K1_HUMAN 2 295 SEQADV 7SIU MET A -15 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP A -14 UNP Q92918 EXPRESSION TAG SEQADV 7SIU TYR A -13 UNP Q92918 EXPRESSION TAG SEQADV 7SIU LYS A -12 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP A -11 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP A -10 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP A -9 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP A -8 UNP Q92918 EXPRESSION TAG SEQADV 7SIU LYS A -7 UNP Q92918 EXPRESSION TAG SEQADV 7SIU GLU A -6 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASN A -5 UNP Q92918 EXPRESSION TAG SEQADV 7SIU LEU A -4 UNP Q92918 EXPRESSION TAG SEQADV 7SIU TYR A -3 UNP Q92918 EXPRESSION TAG SEQADV 7SIU PHE A -2 UNP Q92918 EXPRESSION TAG SEQADV 7SIU GLN A -1 UNP Q92918 EXPRESSION TAG SEQADV 7SIU GLY A 1 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ALA A 257 UNP Q92918 LYS 257 CONFLICT SEQADV 7SIU ALA A 260 UNP Q92918 LYS 260 CONFLICT SEQADV 7SIU ALA A 261 UNP Q92918 LYS 261 CONFLICT SEQADV 7SIU MET B -15 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP B -14 UNP Q92918 EXPRESSION TAG SEQADV 7SIU TYR B -13 UNP Q92918 EXPRESSION TAG SEQADV 7SIU LYS B -12 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP B -11 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP B -10 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP B -9 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASP B -8 UNP Q92918 EXPRESSION TAG SEQADV 7SIU LYS B -7 UNP Q92918 EXPRESSION TAG SEQADV 7SIU GLU B -6 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ASN B -5 UNP Q92918 EXPRESSION TAG SEQADV 7SIU LEU B -4 UNP Q92918 EXPRESSION TAG SEQADV 7SIU TYR B -3 UNP Q92918 EXPRESSION TAG SEQADV 7SIU PHE B -2 UNP Q92918 EXPRESSION TAG SEQADV 7SIU GLN B -1 UNP Q92918 EXPRESSION TAG SEQADV 7SIU GLY B 1 UNP Q92918 EXPRESSION TAG SEQADV 7SIU ALA B 257 UNP Q92918 LYS 257 CONFLICT SEQADV 7SIU ALA B 260 UNP Q92918 LYS 260 CONFLICT SEQADV 7SIU ALA B 261 UNP Q92918 LYS 261 CONFLICT SEQRES 1 A 310 MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN LEU TYR SEQRES 2 A 310 PHE GLN GLY ASP VAL VAL ASP PRO ASP ILE PHE ASN ARG SEQRES 3 A 310 ASP PRO ARG ASP HIS TYR ASP LEU LEU GLN ARG LEU GLY SEQRES 4 A 310 GLY GLY THR TYR GLY GLU VAL PHE LYS ALA ARG ASP LYS SEQRES 5 A 310 VAL SER GLY ASP LEU VAL ALA LEU LYS MET VAL LYS MET SEQRES 6 A 310 GLU PRO ASP ASP ASP VAL SER THR LEU GLN LYS GLU ILE SEQRES 7 A 310 LEU ILE LEU LYS THR CYS ARG HIS ALA ASN ILE VAL ALA SEQRES 8 A 310 TYR HIS GLY SER TYR LEU TRP LEU GLN LYS LEU TRP ILE SEQRES 9 A 310 CYS MET GLU PHE CYS GLY ALA GLY SER LEU GLN ASP ILE SEQRES 10 A 310 TYR GLN VAL THR GLY SER LEU SER GLU LEU GLN ILE SER SEQRES 11 A 310 TYR VAL CYS ARG GLU VAL LEU GLN GLY LEU ALA TYR LEU SEQRES 12 A 310 HIS SER GLN LYS LYS ILE HIS ARG ASP ILE LYS GLY ALA SEQRES 13 A 310 ASN ILE LEU ILE ASN ASP ALA GLY GLU VAL ARG LEU ALA SEQRES 14 A 310 ASP PHE GLY ILE SER ALA GLN ILE GLY ALA THR LEU ALA SEQRES 15 A 310 ARG ARG LEU SER PHE ILE GLY THR PRO TYR TRP MET ALA SEQRES 16 A 310 PRO GLU VAL ALA ALA VAL ALA LEU LYS GLY GLY TYR ASN SEQRES 17 A 310 GLU LEU CYS ASP ILE TRP SER LEU GLY ILE THR ALA ILE SEQRES 18 A 310 GLU LEU ALA GLU LEU GLN PRO PRO LEU PHE ASP VAL HIS SEQRES 19 A 310 PRO LEU ARG VAL LEU PHE LEU MET THR LYS SER GLY TYR SEQRES 20 A 310 GLN PRO PRO ARG LEU LYS GLU LYS GLY LYS TRP SER ALA SEQRES 21 A 310 ALA PHE HIS ASN PHE ILE LYS VAL THR LEU THR ALA SER SEQRES 22 A 310 PRO ALA ALA ARG PRO SER ALA THR LYS MET LEU SER HIS SEQRES 23 A 310 GLN LEU VAL SER GLN PRO GLY LEU ASN ARG GLY LEU ILE SEQRES 24 A 310 LEU ASP LEU LEU ASP LYS LEU LYS ASN PRO GLY SEQRES 1 B 310 MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN LEU TYR SEQRES 2 B 310 PHE GLN GLY ASP VAL VAL ASP PRO ASP ILE PHE ASN ARG SEQRES 3 B 310 ASP PRO ARG ASP HIS TYR ASP LEU LEU GLN ARG LEU GLY SEQRES 4 B 310 GLY GLY THR TYR GLY GLU VAL PHE LYS ALA ARG ASP LYS SEQRES 5 B 310 VAL SER GLY ASP LEU VAL ALA LEU LYS MET VAL LYS MET SEQRES 6 B 310 GLU PRO ASP ASP ASP VAL SER THR LEU GLN LYS GLU ILE SEQRES 7 B 310 LEU ILE LEU LYS THR CYS ARG HIS ALA ASN ILE VAL ALA SEQRES 8 B 310 TYR HIS GLY SER TYR LEU TRP LEU GLN LYS LEU TRP ILE SEQRES 9 B 310 CYS MET GLU PHE CYS GLY ALA GLY SER LEU GLN ASP ILE SEQRES 10 B 310 TYR GLN VAL THR GLY SER LEU SER GLU LEU GLN ILE SER SEQRES 11 B 310 TYR VAL CYS ARG GLU VAL LEU GLN GLY LEU ALA TYR LEU SEQRES 12 B 310 HIS SER GLN LYS LYS ILE HIS ARG ASP ILE LYS GLY ALA SEQRES 13 B 310 ASN ILE LEU ILE ASN ASP ALA GLY GLU VAL ARG LEU ALA SEQRES 14 B 310 ASP PHE GLY ILE SER ALA GLN ILE GLY ALA THR LEU ALA SEQRES 15 B 310 ARG ARG LEU SER PHE ILE GLY THR PRO TYR TRP MET ALA SEQRES 16 B 310 PRO GLU VAL ALA ALA VAL ALA LEU LYS GLY GLY TYR ASN SEQRES 17 B 310 GLU LEU CYS ASP ILE TRP SER LEU GLY ILE THR ALA ILE SEQRES 18 B 310 GLU LEU ALA GLU LEU GLN PRO PRO LEU PHE ASP VAL HIS SEQRES 19 B 310 PRO LEU ARG VAL LEU PHE LEU MET THR LYS SER GLY TYR SEQRES 20 B 310 GLN PRO PRO ARG LEU LYS GLU LYS GLY LYS TRP SER ALA SEQRES 21 B 310 ALA PHE HIS ASN PHE ILE LYS VAL THR LEU THR ALA SER SEQRES 22 B 310 PRO ALA ALA ARG PRO SER ALA THR LYS MET LEU SER HIS SEQRES 23 B 310 GLN LEU VAL SER GLN PRO GLY LEU ASN ARG GLY LEU ILE SEQRES 24 B 310 LEU ASP LEU LEU ASP LYS LEU LYS ASN PRO GLY HET 9ID A 901 31 HET SO4 A 902 5 HET 9ID B 301 31 HETNAM 9ID 6-[(5R)-5-BENZAMIDOCYCLOHEX-1-EN-1-YL]-3-[(1-METHYL-1H- HETNAM 2 9ID PYRAZOL-4-YL)AMINO]PYRAZINE-2-CARBOXAMIDE HETNAM SO4 SULFATE ION FORMUL 3 9ID 2(C22 H23 N7 O2) FORMUL 4 SO4 O4 S 2- FORMUL 6 HOH *704(H2 O) HELIX 1 AA1 ASP A 12 ASP A 15 5 4 HELIX 2 AA2 ASP A 55 CYS A 69 1 15 HELIX 3 AA3 LEU A 99 GLY A 107 1 9 HELIX 4 AA4 SER A 110 GLN A 131 1 22 HELIX 5 AA5 LYS A 139 ALA A 141 5 3 HELIX 6 AA6 GLY A 157 GLN A 161 5 5 HELIX 7 AA7 GLY A 163 GLY A 174 1 12 HELIX 8 AA8 ALA A 180 GLY A 190 1 11 HELIX 9 AA9 LEU A 195 LEU A 211 1 17 HELIX 10 AB1 HIS A 219 LYS A 229 1 11 HELIX 11 AB2 SER A 244 LEU A 255 1 12 HELIX 12 AB3 SER A 258 ARG A 262 5 5 HELIX 13 AB4 SER A 264 LEU A 269 1 6 HELIX 14 AB5 HIS A 271 GLN A 276 1 6 HELIX 15 AB6 ASN A 280 ASN A 293 1 14 HELIX 16 AB7 ASP B 55 CYS B 69 1 15 HELIX 17 AB8 LEU B 99 GLY B 107 1 9 HELIX 18 AB9 SER B 110 GLN B 131 1 22 HELIX 19 AC1 LYS B 139 ALA B 141 5 3 HELIX 20 AC2 GLY B 157 ALA B 160 5 4 HELIX 21 AC3 GLN B 161 ILE B 173 1 13 HELIX 22 AC4 PRO B 181 VAL B 186 1 6 HELIX 23 AC5 LEU B 195 LEU B 211 1 17 HELIX 24 AC6 HIS B 219 LYS B 229 1 11 HELIX 25 AC7 GLU B 239 TRP B 243 5 5 HELIX 26 AC8 SER B 244 LEU B 255 1 12 HELIX 27 AC9 SER B 258 ARG B 262 5 5 HELIX 28 AD1 SER B 264 SER B 270 1 7 HELIX 29 AD2 HIS B 271 GLN B 276 1 6 HELIX 30 AD3 ARG B 281 ASN B 293 1 13 SHEET 1 AA1 5 TYR A 17 GLY A 26 0 SHEET 2 AA1 5 GLY A 29 ASP A 36 -1 O LYS A 33 N LEU A 20 SHEET 3 AA1 5 LEU A 42 LYS A 49 -1 O MET A 47 N GLU A 30 SHEET 4 AA1 5 LYS A 86 GLU A 92 -1 O LEU A 87 N VAL A 48 SHEET 5 AA1 5 TYR A 77 TRP A 83 -1 N TYR A 81 O TRP A 88 SHEET 1 AA2 3 GLY A 97 SER A 98 0 SHEET 2 AA2 3 ILE A 143 ILE A 145 -1 O ILE A 145 N GLY A 97 SHEET 3 AA2 3 VAL A 151 LEU A 153 -1 O ARG A 152 N LEU A 144 SHEET 1 AA3 5 TYR B 17 GLY B 26 0 SHEET 2 AA3 5 GLY B 29 ASP B 36 -1 O LYS B 33 N GLN B 21 SHEET 3 AA3 5 LEU B 42 LYS B 49 -1 O MET B 47 N GLU B 30 SHEET 4 AA3 5 LYS B 86 GLU B 92 -1 O LEU B 87 N VAL B 48 SHEET 5 AA3 5 TYR B 77 TRP B 83 -1 N HIS B 78 O CYS B 90 SHEET 1 AA4 3 GLY B 97 SER B 98 0 SHEET 2 AA4 3 ILE B 143 ILE B 145 -1 O ILE B 145 N GLY B 97 SHEET 3 AA4 3 VAL B 151 LEU B 153 -1 O ARG B 152 N LEU B 144 CRYST1 69.370 69.370 323.590 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014415 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014415 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003090 0.00000